Key Takeaways
- • Waverunner Capital Inc. (CHM.CN / CHMJF) experienced a 900% stock price surge in April 2026, marking significant volatility in a micro-cap venture capital vehicle trading on Canadian exchanges with a market capitalization of approximately $1.33 million as of mid-April 2026.
- • The company operates as a venture capital and investment firm focused on early-stage seed/startup investments, PIPEs, bridge financing, growth capital, and secondary limited partner interests across Europe and North America, with investment targets between CAD $500k–$1 million and enterprise values of CAD $2–$5 million.
- • Portfolio exposure spans resources, renewable energy (wind and solar), plant-based wellness, and consumer-targeted biotechnology, positioning the firm within diversified alternative investment sectors, though the company maintains a highly illiquid balance sheet with a quick ratio of 0.10, indicating potential difficulty covering short-term liabilities.
- • Corporate rebranding from Chemistree Technology Inc. to Waverunner Capital Inc. occurred in June 2024, reflecting a strategic pivot toward venture capital operations and signaling management repositioning in the firm's investment thesis.
- • The stock exhibits extreme volatility with a 5-year beta of 3.40 and a 52-week range of CAD $0.0400–$0.2050, characteristic of micro-cap, illiquid securities with limited institutional participation and high speculative trading dynamics.
Summary
Waverunner Capital Inc., trading under ticker symbols CHM.CN (Canadian Securities Exchange) and CHMJF (over-the-counter U.S. markets), reported a 900% stock price surge during April 2026, reflecting the extreme volatility inherent in micro-cap venture capital securities. As of April 13, 2026, the company maintained a market capitalization of approximately $1.33 million CAD, with the stock priced at $0.1350 CAD at the previous close on April 9, having traded within a 52-week range of $0.0400 to $0.2050. The move represents characteristic behavior for illiquid, thinly traded securities in the venture capital space where limited float and sporadic trading volume amplify price movements.
The firm, formerly known as Chemistree Technology Inc. until its June 2024 rebranding, operates as a venture capital and investment company with a stated investment strategy focused on early-stage and seed-stage investments, along with PIPEs (private investments in public equity), bridge financing, recapitalizations, and secondary limited partner interest acquisitions. The company targets investments between CAD $500,000 and CAD $1 million with portfolio company enterprise values ranging from CAD $2 million to CAD $5 million, concentrating its deployment across Europe and North America. Portfolio holdings span resources, renewable energy sectors (including wind and solar installations), plant-based wellness companies, and consumer-targeted biotechnology ventures.
Financial metrics as of April 2026 reveal structural challenges typical of undercapitalized venture vehicles: the company reported operating cash flow of approximately $419,980 (TTM), negative earnings per share of -$0.0700, and a concerning quick ratio of 0.10, suggesting potential liquidity constraints in meeting short-term obligations. The company finances investments through its own balance sheet and personal capital structures, a model limiting capital deployment capacity relative to institutional venture partners. Trading metrics underscore extreme volatility, with a 5-year beta of 3.40—substantially elevated relative to broad market indices—and average daily volume of only 1,668 shares, indicating minimal institutional participation and high sensitivity to speculative trading dynamics. As of mid-April 2026, the company reported no forward dividend yield, no near-term earnings dates, and no analyst price targets, further reflecting the micro-cap, speculative nature of the security.
For institutional investors and hedge funds monitoring Canadian venture capital securities and micro-cap plays, Waverunner Capital represents a highly illiquid, speculative position characterized by extreme price volatility, limited fundamental transparency, and structural balance sheet constraints. The April 2026 price surge should be viewed within the context of thinly traded securities where modest volume can generate outsized percentage movements disconnected from underlying business fundamentals.
The firm, formerly known as Chemistree Technology Inc. until its June 2024 rebranding, operates as a venture capital and investment company with a stated investment strategy focused on early-stage and seed-stage investments, along with PIPEs (private investments in public equity), bridge financing, recapitalizations, and secondary limited partner interest acquisitions. The company targets investments between CAD $500,000 and CAD $1 million with portfolio company enterprise values ranging from CAD $2 million to CAD $5 million, concentrating its deployment across Europe and North America. Portfolio holdings span resources, renewable energy sectors (including wind and solar installations), plant-based wellness companies, and consumer-targeted biotechnology ventures.
Financial metrics as of April 2026 reveal structural challenges typical of undercapitalized venture vehicles: the company reported operating cash flow of approximately $419,980 (TTM), negative earnings per share of -$0.0700, and a concerning quick ratio of 0.10, suggesting potential liquidity constraints in meeting short-term obligations. The company finances investments through its own balance sheet and personal capital structures, a model limiting capital deployment capacity relative to institutional venture partners. Trading metrics underscore extreme volatility, with a 5-year beta of 3.40—substantially elevated relative to broad market indices—and average daily volume of only 1,668 shares, indicating minimal institutional participation and high sensitivity to speculative trading dynamics. As of mid-April 2026, the company reported no forward dividend yield, no near-term earnings dates, and no analyst price targets, further reflecting the micro-cap, speculative nature of the security.
For institutional investors and hedge funds monitoring Canadian venture capital securities and micro-cap plays, Waverunner Capital represents a highly illiquid, speculative position characterized by extreme price volatility, limited fundamental transparency, and structural balance sheet constraints. The April 2026 price surge should be viewed within the context of thinly traded securities where modest volume can generate outsized percentage movements disconnected from underlying business fundamentals.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.